Clinical trial
Investigation of the Human Immune Response in Normal Subjects and Patients With…
NCT00001582 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001582 |
|---|---|
| Title | Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer |
| Official title | Collection of Blood, Bone Marrow and Tissue Samples for the Investigation of the Human Immune Response, Lymphoma Biology and HTLV-1 Infection |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | T-cell Lymphoma, B-Cell Lymphoma, ATL, Myeloma |
| Enrollment | 902 |
| Start date | Jun 7, 1997 |
| Primary completion | Mar 17, 2023 |
| Completion | Mar 17, 2023 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 21, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: